Barbara Mora

Author PubWeight™ 26.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010 6.90
2 Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011 6.36
3 Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts. Blood 2014 1.87
4 Patchy villous atrophy of the duodenum in childhood celiac disease. J Pediatr Gastroenterol Nutr 2004 1.77
5 Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007 1.70
6 HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol 2008 1.65
7 HLA-DQ and risk gradient for celiac disease. Hum Immunol 2008 1.47
8 Expression of neuronal markers during NTera2/cloneD1 differentiation by cell aggregation method. Neurosci Lett 2005 0.94
9 Minor expression of fascin-1 gene (FSCN1) in NTera2 cells depleted of CREB-binding protein. Neurosci Lett 2005 0.93
10 Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr 2006 0.89
11 Analysis of candidate genes on chromosomes 5q and 19p in celiac disease. J Pediatr Gastroenterol Nutr 2007 0.84
12 A rapid and sensitive method to detect specific human lymphocyte antigen (HLA) class II alleles associated with celiac disease. Clin Chem Lab Med 2008 0.81
13 Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population. Arch Dermatol Res 2013 0.77
14 HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease. J Pediatr Gastroenterol Nutr 2008 0.77
15 Immunogenetic investigation in vernal keratoconjunctivitis. Pediatr Allergy Immunol 2014 0.75
16 New molecular genetics in the diagnosis and treatment of myeloproliferative neoplasms. Curr Opin Hematol 2016 0.75